(2E)-2-Hexenoic acid beta-D-glucopyranosyl ester

Details

Top
Internal ID c136eab7-69dc-43d1-9e60-04c736645249
Taxonomy Lipids and lipid-like molecules > Fatty Acyls > Fatty acyl glycosides > Fatty acyl glycosides of mono- and disaccharides
IUPAC Name [(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl] (E)-hex-2-enoate
SMILES (Canonical) CCCC=CC(=O)OC1C(C(C(C(O1)CO)O)O)O
SMILES (Isomeric) CCC/C=C/C(=O)O[C@H]1[C@@H]([C@H]([C@@H]([C@H](O1)CO)O)O)O
InChI InChI=1S/C12H20O7/c1-2-3-4-5-8(14)19-12-11(17)10(16)9(15)7(6-13)18-12/h4-5,7,9-13,15-17H,2-3,6H2,1H3/b5-4+/t7-,9-,10+,11-,12+/m1/s1
InChI Key GVALZBNAMDMDDL-RJFPCNKHSA-N
Popularity 0 references in papers

Physical and Chemical Properties

Top
Molecular Formula C12H20O7
Molecular Weight 276.28 g/mol
Exact Mass 276.12090297 g/mol
Topological Polar Surface Area (TPSA) 116.00 Ų
XlogP -0.20
Atomic LogP (AlogP) -1.31
H-Bond Acceptor 7
H-Bond Donor 4
Rotatable Bonds 5

Synonyms

Top
There are no found synonyms.

2D Structure

Top
2D Structure of (2E)-2-Hexenoic acid beta-D-glucopyranosyl ester

3D Structure

Top

ADMET Properties (via admetSAR 2)

Top
Target Value Probability (raw) Probability (%)
Human Intestinal Absorption - 0.6930 69.30%
Caco-2 - 0.8287 82.87%
Blood Brain Barrier + 0.5250 52.50%
Human oral bioavailability - 0.8286 82.86%
Subcellular localzation Mitochondria 0.8027 80.27%
OATP2B1 inhibitior - 0.8597 85.97%
OATP1B1 inhibitior + 0.8491 84.91%
OATP1B3 inhibitior + 0.9534 95.34%
MATE1 inhibitior - 0.8400 84.00%
OCT2 inhibitior - 0.9000 90.00%
BSEP inhibitior - 0.9556 95.56%
P-glycoprotein inhibitior - 0.9445 94.45%
P-glycoprotein substrate - 0.9647 96.47%
CYP3A4 substrate + 0.5000 50.00%
CYP2C9 substrate - 1.0000 100.00%
CYP2D6 substrate - 0.8795 87.95%
CYP3A4 inhibition - 0.8906 89.06%
CYP2C9 inhibition - 0.8913 89.13%
CYP2C19 inhibition - 0.8406 84.06%
CYP2D6 inhibition - 0.9292 92.92%
CYP1A2 inhibition - 0.8994 89.94%
CYP2C8 inhibition - 0.8773 87.73%
CYP inhibitory promiscuity - 0.8807 88.07%
UGT catelyzed + 0.6000 60.00%
Carcinogenicity (binary) - 0.9800 98.00%
Carcinogenicity (trinary) Non-required 0.7428 74.28%
Eye corrosion - 0.9859 98.59%
Eye irritation - 0.9677 96.77%
Skin irritation - 0.7958 79.58%
Skin corrosion - 0.9477 94.77%
Ames mutagenesis - 0.8100 81.00%
Human Ether-a-go-go-Related Gene inhibition - 0.6040 60.40%
Micronuclear - 0.8800 88.00%
Hepatotoxicity - 0.8912 89.12%
skin sensitisation - 0.8686 86.86%
Respiratory toxicity - 0.7444 74.44%
Reproductive toxicity - 0.6667 66.67%
Mitochondrial toxicity - 0.7125 71.25%
Nephrotoxicity - 0.6528 65.28%
Acute Oral Toxicity (c) III 0.6422 64.22%
Estrogen receptor binding - 0.7677 76.77%
Androgen receptor binding - 0.7396 73.96%
Thyroid receptor binding - 0.5877 58.77%
Glucocorticoid receptor binding - 0.5655 56.55%
Aromatase binding - 0.8076 80.76%
PPAR gamma + 0.5563 55.63%
Honey bee toxicity - 0.8862 88.62%
Biodegradation + 0.5500 55.00%
Crustacea aquatic toxicity - 0.7355 73.55%
Fish aquatic toxicity - 0.5479 54.79%

Targets

Top

Proven Targets:

CHEMBL ID UniProt ID Name Min activity Assay type Source
No proven targets yet!

Predicted Targets (via Super-PRED):

CHEMBL ID UniProt ID Name Probability Model accuracy
CHEMBL3251 P19838 Nuclear factor NF-kappa-B p105 subunit 93.32% 96.09%
CHEMBL3060 Q9Y345 Glycine transporter 2 90.65% 99.17%
CHEMBL5619 P27695 DNA-(apurinic or apyrimidinic site) lyase 87.06% 91.11%
CHEMBL3714130 P46095 G-protein coupled receptor 6 85.77% 97.36%
CHEMBL5255 O00206 Toll-like receptor 4 85.73% 92.50%
CHEMBL1293267 Q9HC97 G-protein coupled receptor 35 83.94% 89.34%
CHEMBL3401 O75469 Pregnane X receptor 83.78% 94.73%
CHEMBL2111367 P27986 PI3-kinase p110-alpha/p85-alpha 82.25% 94.33%
CHEMBL4793 Q86TI2 Dipeptidyl peptidase IX 81.87% 96.95%
CHEMBL2581 P07339 Cathepsin D 81.32% 98.95%
CHEMBL1075094 Q16236 Nuclear factor erythroid 2-related factor 2 80.47% 96.00%

Cross-Links

Top
PubChem 101347691
NPASS NPC76078